Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study: Research paper

British Journal of Haematology

Volumn 148, Issue 6, 2010, Pages 918-924

  Andersson, Therese M L ^a   Lambert, Paul C ^a,b   Derolf, Åsa Rangert ^c   Kristinsson, Sigurdur Yngvi ^c   Eloranta, Sandra ^a   Landgren, Ola ^c,d   Björkholm, Magnus ^c   Dickman, Paul W ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Acute myeloid leukaemia; Cure models; Population based study; Relative survival; Survival

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; HEALTH CARE PERSONNEL; HEALTH ECONOMICS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SWEDEN; AGE DISTRIBUTION; EPIDEMIOLOGY; FEMALE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MORTALITY; REGISTER; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MORTALITY; REGISTRIES; SWEDEN; YOUNG ADULT;

EID: 77649207386     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.08026.x     Document Type: Article

References (42)

1. Barlow, L., Westergren, K., Holmberg, L. Talback, M. (2009) The completeness of the Swedish Cancer Register - a sample survey for year 1998. Acta Oncologica, 48, 27 33.
2. Björkholm, M., Liliemark, J., Gahrton, G., Grimfors, G., Gruber, A., Hast, R., Juliusson, G., Järnmark, M., Killander, A., Kimby, E., Lerner, R., Ljungman, P., Lönnqvist, B., Palmblad, J., Paul, C., Petterson, C., Simonsson, B., Stalfelt, A.-M., Stenke, L., Sundström, C., Tidefelt, U., Uden, A.-M., Öberg, G. Öst, A. (1995) Mitoxantrone, etoposide and ara-C vs doxorubicin-DNA, ara-C, thioguanine, vincristine and prednisolone in the treatment of patients with acute myelocytic leukaemia. A randomized comparison. European Journal of Haematology, 55, 19 23.
3. Bloomfield, C.D., Lawrence, D., Byrd, J.C., Carroll, A., Pettenati, M.J., Tantravahi, R., Patil, S.R., Davey, F.R., Berg, D.T., Schiffer, C.A., Arthur, D.C. Mayer, R.J. (1998) Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Research, 58, 4173 4179.
4. Boeckh, M. Ljungman, P. (2009) How we treat cytomegalovirus in hematopoietic cell transplant recipients. Blood, 113, 5711 5719.
5. Boiron, M., Weil, M., Jacquillat, C., Tanzer, J., Levy, D., Sultan, C. Bernard, J. (1969) Daunorubicin in the treatment of acute myelocytic leukaemia. Lancet, 1, 330 333.
6. Burnett, A.K. (2005) The treatment of AML: current status and novel approaches. Hematology, 10 (Suppl. 1 50 53.
7. Cassileth, P.A., Begg, C.B., Bennett, J.M., Bozdech, M., Kahn, S.B., Weiler, C. Glick, J.H. (1984) A randomized study of the efficacy of consolidation therapy in adult acute nonlymphocytic leukemia. Blood, 63, 843 847.
8. Cornelissen, J.J., van Putten, W.L., Verdonck, L.F., Theobald, M., Jacky, E., Daenen, S.M., van Marwijk Kooy, M., Wijermans, P., Schouten, H., Huijgens, P.C., van der Lelie, H., Fey, M., Ferrant, A., Maertens, J., Gratwohl, A. Lowenberg, B. (2007) Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom? Blood, 109, 3658 3666.
9. Cornely, O.A., Böhme, A., Buchheidt, D., Einsele, H., Heinz, W.J., Karthaus, M., Krause, S.W., Krüger, W., Maschmeyer, G., Penack, O., Ritter, J., Ruhnke, M., Sandherr, M., Sieniawski, M., Vehreschild, J.J., Wolf, H.H. Ullmann, A.J. (2009) Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology. Haematologica, 94, 113 122.
10. De Angelis, R., Capocaccia, R., Hakulinen, T., Soderman, B. Verdecchia, A. (1999) Mixture models for cancer survival analysis: application to population-based data with covariates. Statistics in Medicine, 18, 441 454.
11. Derolf, A.R., Kristinsson, S.Y., Andersson, T.M.-L., Landgren, O., Dickman, P.W. Björkholm, M. (2009) Improved patient survival for acute myeloid leukemia: a population-based study of 9,729 patients diagnosed in Sweden 1973-2005. Blood, 113, 3666 3672.
12. Dickman, P.W. Adami, H.O. (2006) Interpreting trends in cancer patient survival. Journal of Internal Medicine, 260, 103 117.
13. Dickman, P.W., Sloggett, A., Hills, M. Hakulinen, T. (2004) Regression models for relative survival. Statistics in Medicine, 23, 51 64.
14. Durrleman, S. Simon, R. (1989) Flexible regression models with cubic splines. Statistics in Medicine, 8, 551 561.
15. Ederer, F. Heise, H. (1959) Instructions to IBM 650 Programmers in Processing Survival Computations. Methodological note No. 10. End Results Evaluation Section, National Cancer Institute, Bethesda MD.
16. Ederer, F., Axtell, L.M. Cutler, S.J. (1961) The relative survival rate: a statistical methodology. National Cancer Institute Monograph, 6, 101 121.
17. Ellison, R.R., Holland, J.F., Weil, M., Jacquillat, C., Boiron, M., Bernard, J., Sawitsky, A., Rosner, F., Gussoff, B., Silver, R.T., Karanas, A., Cuttner, J., Spurr, C.L., Hayes, D.M., Blom, J., Leone, L.A., Haurani, F., Kyle, R., Hutchison, J.L., Forcier, R.J. Moon, J.H. (1968) Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood, 32, 507 523.
18. Estey, E. Dohner, H. (2006) Acute myeloid leukaemia. Lancet, 368, 1894 1907.
19. Gahrton, G., Björkholm, M., Brenning, G., Christenson, I., Engstedt, L., Franzén, S., Gullbring, B., Holm, G., Högman, C., Hörnsten, P., Jameson, S., Killander, A., Simonsson-Lindemalm, C., Lockner, D., Lönnqvist, B., Mellstedt, H., Palmblad, J., Paul, C., Pauli, C., Peterson, C., Reizenstein, P., Simonsson, B., Skrberg, K.O., Udén, A.M. Wadman, B. (1979) Treatment of acute nonlymphoblastic leukemia in adults with daunorubicin-DNA complex: a preliminary report. Cancer Chemotherapy and Pharmacology, 2, 73 76.
20. Hutchins, L.F., Unger, J.M., Crowley, J.J., Coltman, Jr., C.A. Albain, K.S. (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. New England Journal of Medicine, 341, 2061 2067.
21. Juliusson, G., Höglund, M., Karlsson, K., Löfgren, C., Möllgrd, L., Paul, C., Tidefelt, U. Björkholm, M. (2003) Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine: a randomized population-based phase II study. British Journal of Haematology, 123, 810 818.
22. Juliusson, G., Billstrom, R., Gruber, A., Hellstrom-Lindberg, E., Hoglunds, M., Karlsson, K., Stockelberg, D., Wahlin, A., Aström, M., Arnesson, C., Brunell-Abrahamsson, U., Carstensen, J., Fredriksson, E., Holmberg, E., Nordenskjöld, K., Wiklund, F. Swedish Adult Acute Leukemia Registry Group (2006) Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival. Leukemia, 20, 42 47.
23. Lambert, P.C. (2007) Modeling of the cure fraction in survival studies. The Stata Journal, 7, 351 375.
24. Lambert, P.C., Thompson, J.R., Weston, C.L. Dickman, P.W. (2007a) Estimating and modelling the cure fraction in population-based cancer survival analysis. Biostatistics, 8, 576 594.
25. Lambert, P.C., Dickman, P.W., Österlund, P., Andersson, T., Sankila, R. Glimelius, B. (2007b) Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry. International Journal of Cancer, 121, 2052 2059.
26. Lambert, P.C., Dickman, P.W., Weston, C.L. Thompson, J.R. (2009) Estimating the cure fraction in population-based cancer studies using finite mixture models. Journal of the Royal Statistical Society Series C, Applied statistics, DOI:.
27. Leith, C.P., Kopecky, K.J., Godwin, J., McConnell, T., Slovak, M.L., Chen, I.M., Head, D.R., Appelbaum, F.R. Willman, C.L. (1997) Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood, 89, 3323 3329.
28. Löfgren, C., Paul, C., Aström, M., Hast, R., Hedenius, M., Lerner, R., Liljemark, J., Nilsson, I., Rödjer, S., Simonsson, B., Stockelberg, D., Tidefelt, U. Björkholm, M. (2004) Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial. British Journal of Haematology, 124, 474 480.
29. Löwenberg, B. (2001) Managing therapy in older adult patients with acute myeloid leukemia. Seminars in Hematology, 38 (3Suppl. 6 10 16.
30. Mattsson, B. Wallgren, A. (1984) Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiologica Oncology, 23, 305 313.
31. Mayer, R.J., Davis, R.B., Schiffer, C.A., Berg, D.T., Powell, B.L., Schulman, P., Omura, G.A., Moore, J.O., McIntyre, O.R. Frei, 3rd., E. (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. New England Journal of Medicine, 331, 896 903.
32. Meijer, E. Cornelissen, J.J. (2008) Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality. Seminars in Oncology, 35, 449 457.
33. Phekoo, K.J., Richards, M.A., Møller, H., Schey, S.A. South Thames Haematology Specialist Committee. (2006) The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England. Haematologica, 91, 1400 1404.
34. Pizzo, P.A., Robichaud, K.J., Gill, F.A. Witebsky, F.G. (1982) Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. American Journal of Medicine, 72, 101 111.
35. Preisler, H.D., Raza, A., Early, A., Kirshner, J., Brecher, M., Freeman, A., Rustum, Y., Azarnia, N., Priore, R. Sandberg, A. (1987) Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia. Journal of Clinical Oncology, 5, 722 730. (Pubitemid 17120248)
36. Pulte, D., Gondos, A. Brenner, H. (2008) Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica, 93, 594 600.
37. Schiller, G., Gajewski, J., Territo, M., Nimer, S., Lee, M., Belin, T. Champlin, R. (1992) Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia. Blood, 80, 2977 2982.
38. Segal, B.H. Freifeld, A.G. (2007) Antibacterial prophylaxis in patients with neutropenia. Journal of the National Comprehensive Cancer Network, 5, 235 242.
39. Suciu, S., Mandelli, F., de Witte, T., Zittoun, R., Gallo, E., Labar, B., De Rosa, G., Belhabri, A., Giustolisi, R., Delarue, R., Liso, V., Mirto, S., Leone, G., Bourhis, J.H., Fioritoni, G., Jehn, U., Amadori, S., Fazi, P., Hagemeijer, A., Willemze, R. EORTC & Leukemia Groups, GIMEMA 2003) Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial. Blood, 102, 1232 1240.
40. Swedish Cancer Registry, The National Board of Health and Welfare 2008) Cancer Incidence in Sweden 2007. National Board of Health and Welfare. Health and Diseases 2008:11. [ http://www.socialstyrelsen.se/Lists/Artikelkatalog/ Attachments/8715/2008-125-16-200812516-rev2.pdf ] Accessed on 6 October 2009.
41. Turesson, I., Linet, M.S., Björkholm, M., Kristinsson, S.Y., Goldin, L.R., Caporaso, N.E. Landgren, O. (2007) Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. International Journal of Cancer, 121, 2260 2266.
42. Verdecchia, A., De Angelis, R., Capocaccia, R., Sant, M., Micheli, A., Gatta, G. Berrino, F. (1998) The cure for colon cancer: results from the EUROCARE study. International Journal of Cancer, 77, 322 329.